For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of Tafamidis and Attruby represents a genuine advancement . These groundbreaking therapies protect the transthyretin protein, preventing its harmful build-up and lessening the burden of the disease . Patients are now experiencing positiv… Read More